Brian Abeysekera
Plus aucun poste en cours
Profil
Brian Abeysekera has been Vice President-Marketing of Molecular Insight Pharmaceuticals, Inc. since April 2007.
He has over 20 years of experience in radioisotope and radiopharmaceutical development, including production, radiochemistry, quality control, quality assurance and regulatory affairs activities in the United States and Canada.
Previously, he served as Director of Applied Research and Development MDS Nordion, Inc. Dr. Abeysekera received a PhD in Synthetic Organic Chemistry from the University of British Columbia.
Anciens postes connus de Brian Abeysekera
| Sociétés | Poste | Fin |
|---|---|---|
MDS Nordion, Inc.
 MDS Nordion, Inc. Pharmaceuticals: OtherHealth Technology MDS Nordion, Inc. use to export medical isotopes, radio therapeutics and related technologies. Its products and services were used in hospitals, clinics, large medical supply companies, biotechnology, pharmaceutical companies, food processors and manufacturers. The company was founded in 1946 and was headquartered in Ottawa, Canada. | Directeur Technique/Scientifique/R&D | - |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Brian Abeysekera
| University of British Columbia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
MDS Nordion, Inc.
MDS Nordion, Inc. Pharmaceuticals: OtherHealth Technology MDS Nordion, Inc. use to export medical isotopes, radio therapeutics and related technologies. Its products and services were used in hospitals, clinics, large medical supply companies, biotechnology, pharmaceutical companies, food processors and manufacturers. The company was founded in 1946 and was headquartered in Ottawa, Canada. | Health Technology |
